Stay updated on Pembrolizumab Combination in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combination in Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Combination in Advanced Melanoma Clinical Trial page
- Check5 days agoChange DetectedA government funding notice about potential delays and NIH operating status was added, and the site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check12 days agoChange DetectedAdded a Show glossary toggle, updated QC metadata (Last Update Submitted that Met QC Criteria) and a No FEAR Act Data footer note with revision v3.4.0; removed the older Last Update Submitted that met QC Criteria, No FEAR Act data, and revision v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.3.4 from v3.3.3; no substantive changes to study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded a new Locations section with North Holland and updated the page to Revision v3.3.3. The previous North Holland Locations entry and the HHS Vulnerability Disclosure link were removed (previous revision v3.3.2).SummaryDifference0.2%

- Check76 days agoChange DetectedThe Publications section now states that entries are automatically filled from PubMed and may not be about the study, and the revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page no longer displays a government funding/operating status notice. Core study information, contacts, and eligibility criteria remain unchanged.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab Combination in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combination in Advanced Melanoma Clinical Trial page.